Description
CNX-774 inhibits Bruton’s tyrosine kinase (BTK) and displays potential anticancer and immunosuppressive activities.
Product Unit Size | Cost | Quantity | Stock |
---|
CNX-774 inhibits Bruton’s tyrosine kinase (BTK) and displays potential anticancer and immunosuppressive activities.
Cas No. | 1202759-32-7 |
---|---|
Purity | ≥98% |
Formula | C26H22FN7O3 |
Formula Wt. | 499.50 |
Chemical Name | 4-[4-[[5-fluoro-4-[3-(prop-2-enoylamino)anilino]pyrimidin-2-yl]amino]phenoxy]-N-methylpyridine-2-carboxamide |
IUPAC Name | 4-[4-[[5-fluoro-4-[3-(prop-2-enoylamino)anilino]pyrimidin-2-yl]amino]phenoxy]-N-methylpyridine-2-carboxamide |
Synonym | CNX774 |
Solubility | DMSO 100 mg/mL (200.2 mM) Ethanol 2 mg/mL (4.0 mM) Water Insoluble |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Akinleye A, Chen Y, Mukhi N, et al. Ibrutinib and novel BTK inhibitors in clinical development. J Hematol Oncol. 2013 Aug 19;6:59. PMID: 23958373.
Nucleobase (adenine) analog; DNA polymerase inh...
Non-steroid; AR antagonist.
Extract containing catechins and flavonoids fou...
Pan inhibitor of ALK.
Anthraquinone, Mg2+/Zn2+ chelator; bacterial DN...
PKD inhibitor.
β2-adrenergic agonist.
Non-depolarizing NMJ blocker; nAChR antagonist....
ALK4/5/7 (activin-like) inhibitor, TGF-β inhib...
Loratadine metabolite; FIASMA, histamine H1 ant...
Endogenous sulfonic acid involved in Ca2+ signa...
Benzophenanthridine alkaloid, sanguinarine meta...
RET inhibitor.
Calcium channel blocker.
BRD binding agent, CDK1/2/5/9 inhibitor.
Antifungal agent with neuroprotective activity....
CDK4/6 inhibitor.
Toxin found in Aconitum; voltage-gated Na+ chan...
Endogenous peptide hormone fragment, involved i...
MEK1/2 inhibitor.